The Perfect Holiday Gift Gift Now

US tariffs: Mid-sized pharma firms search for cure

Financial Express Kolkata

|

April 18, 2025

Communicable disease drugs in focus for local market; many look at API segment

- Krishna Barot

As the Indian pharma sector grapples with uncertainties of US President Donald Trump's potential tariff announcement, smaller players are formulating a survival strategy. The plan includes pursuing niche segments in the domestic market, and finding new export destinations to compensate for any potential loss of the US market.

The prohibitive US tariffs on China may also encourage many mid-sized Indian firms to go upstream and manufacture bulk drugs—active pharmaceutical ingredients or APIs. According to Nilesh Patel, managing director at Kashmik Formulation, the drugs meant for non-communicable diseases (NCDs), also known as lifestyle diseases, could be in focus. "Our company is exploring therapies for NCD segments such as cardiovascular diseases and obesity. Additionally, we are also exploring opportunities in API manufacturing."

MORE STORIES FROM Financial Express Kolkata

Financial Express Kolkata

Gig workers earn ₹102 per hour: Eternal CEO Goyal

PARTNERS WORKING FULL-TIME WILL EARN ₹21,000 NET MONTHLY PAY

time to read

1 mins

January 03, 2026

Financial Express Kolkata

Tax liability on capital gains as per ownership share in house

• I have a joint property with my mother.

time to read

2 mins

January 03, 2026

Financial Express Kolkata

EU carbon tax to hit steel firms

INDIAN STEELMAKERS EXPORTING to Europe are preparing for higher costs, lower margins and tougher choices as the European Union's Carbon Border Adjustment Mechanism (CBAM) begins to bite. Industry estimates suggest that once carbon costs are fully reflected, export prices could rise by 15-22%, a shift that directly affects volumes, profitability and long-term market presence.

time to read

2 mins

January 03, 2026

Financial Express Kolkata

Gig debate raises an online storm

Zomato founder's posts on strike draw brickbats and some bouquets

time to read

1 min

January 03, 2026

Financial Express Kolkata

Equity funds surge in final week of 2025

GLOBAL EQUITY FUNDS saw strong inflows in the final week of 2025 as optimism over AIdriven market gains over the past year and a solid corporate earnings outlook lifted risk appetite.

time to read

1 min

January 03, 2026

Financial Express Kolkata

The World Cup is Nike's to lose versus Adidas

WHENTHE FIFA World Cup kicks off in North America in June, the trophy won’t be the only prize up for grabs.

time to read

3 mins

January 03, 2026

Financial Express Kolkata

Active users emerge as telcos' new battleground

THE ACTIVE SUBSCRIBER base, rather than headline subscriber additions, is emerging as the new battleground in India's telecom market, analysts said, as November data highlighted the contrast between operational momentum and reported scale.

time to read

1 min

January 03, 2026

Financial Express Kolkata

Nifty smashes record

• Earnings outlook, positive global cues drive rally; investors richer by ₹4.33L cr

time to read

1 min

January 03, 2026

Financial Express Kolkata

Era of polished posts over: Instagram chief

INSTAGRAM HEAD ADAM Mosseri has warned that artificial intelligence will upend how people create and interpret visual content online, predicting the end of the “polished” aesthetic and the rise of a more “raw” and imperfect social-media style.

time to read

2 mins

January 03, 2026

Financial Express Kolkata

Hindustan Zinc output rises, silver drops in Q3

VEDANTA GROUP FIRM Hindustan Zinc (HZL) on Friday reported a 4% rise in mined metal output to 2,76,000 tonnes in the third quarter of the current fiscal year, primarily on account of higher ore production.

time to read

1 min

January 03, 2026

Listen

Translate

Share

-
+

Change font size